Aptevo Therapeutics Inc.
APVO | NASDAQ
$1.84
$0 (0.00%)
At close: Sep 21, 2026, 3:59 PM ET
$1.88
+$0.04 (+2.28%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.11M | 3.67M | 3.1M | 3.11M | 2.42M |
Cost of Revenue | n/a | 35K | 81K | n/a | n/a | n/a | 71K | n/a | n/a | 106K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.87M | 4.54M | 4.37M | 4.72M | 5.36M |
Gross Profit | n/a | -35K | -81K | n/a | n/a | n/a | -71K | n/a | n/a | -106K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.75M | -878K | -1.27M | -1.61M | -2.94M |
Operating Income | -6.44M | -6.84M | -6M | -7.61M | -6.23M | -6.48M | -6.38M | -5.21M | -6.02M | -6.98M | -6.38M | -6.56M | -8.18M | -7.76M | -7.68M | -7.78M | -7.56M | -5.61M | -4.04M | -4.75M | -5.72M | -6.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.36M | -6.7M | -5.81M | -7.55M | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -6.2M | -6.33M | -7.95M | 1.83M | -5.16M | -7.81M | 27.86M | -7.88M | -6.6M | -7.08M | -8.06M | -7.67M |
Net Income | -6.36M | -6.7M | -5.81M | -7.55M | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -5.9M | -6.33M | -7.95M | 2.77M | -4.64M | -7.64M | 28.01M | -7.7M | -6.27M | -7M | -7.93M | -7.26M |
Selling & General & Admin | 2.75M | 2.91M | 2.46M | 3.57M | 2.9M | 2.85M | 2.5M | 2.11M | 2.38M | 3.23M | 2.79M | 2.67M | 2.72M | 3.59M | 3.01M | 3.31M | 3.7M | 3.86M | 3.16M | 3.48M | 4.11M | 3.95M |
Research & Development | 3.7M | 3.89M | 3.54M | 4.04M | 3.33M | 3.63M | 3.88M | 3.1M | 3.64M | 3.65M | 3.59M | 3.89M | 5.46M | 4.17M | 4.67M | 4.48M | 3.87M | 4.87M | 4.54M | 4.37M | 4.72M | 5.36M |
Other Expenses | n/a | n/a | -81K | n/a | n/a | n/a | -71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.87M | -4.54M | -4.37M | -4.72M | -5.36M |
Operating Expenses | 6.44M | 6.8M | 5.92M | 7.61M | 6.23M | 6.48M | 6.31M | 5.21M | 6.02M | 6.88M | 6.38M | 6.56M | 8.18M | 7.76M | 7.68M | 7.78M | 7.56M | 3.86M | 3.16M | 3.48M | 4.11M | 3.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.44M | 6.84M | 6M | 7.61M | 6.23M | 6.48M | 6.38M | 5.21M | 6.02M | 6.98M | 6.38M | 6.56M | 8.18M | 7.76M | 7.68M | 7.78M | 7.56M | 8.73M | 7.71M | 7.85M | 8.83M | 9.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.2M | 1.06M | 997.83K | 224.95K | 41.01K | 4.05K | 4.05K | 791.93 | 264.25 | 51.56 | 33.22 | 21.46 | 11.06 | 11.98 | 11.03 | 8.69 | 8.57 | 8.42 | 8.36 | 8.35 | 7.74 | 7.54 |
Shares Outstanding (Diluted) | 1.2M | 1.06M | 997.83K | 224.95K | 41.01K | 4.05K | 4.05K | 791.93 | 264.25 | 51.56 | 33.22 | 21.46 | 11.06 | 11.98 | 11.03 | 8.69 | 8.57 | 8.42 | 8.36 | 8.35 | 7.74 | 7.54 |
EPS (Basic) | -5.31 | -6.41 | -159.33 | -40.13 | -151.29 | -1.58K | -1.56K | -6.44K | -22.26K | -132.55K | -177.71K | -295.11K | -718.61K | 231.44K | -420.74K | -880.05K | 3.27M | -913.64K | -750.47K | -838.29K | -1.02M | -962.46K |
EPS (Diluted) | -5.31 | -6.41 | -159.33 | -40.13 | -151.29 | -1.58K | -1.56K | -6.44K | -22.26K | -132.55K | -177.71K | -295.11K | -718.61K | 231.44K | -420.74K | -880.05K | 3.27M | -913.64K | -750.47K | -838.29K | -1.02M | -962.46K |
EBITDA | -6.53M | -6.66M | -5.73M | -7.5M | -6.16M | -6.35M | -6.24M | -5.02M | -5.79M | -6.73M | -6.08M | -6.21M | -7.8M | 2.01M | -5M | -7.59M | 28.14M | -7.63M | -6.34M | -6.78M | -7.77M | -6.59M |
EBIT | -6.53M | -6.7M | -5.81M | -7.55M | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -6.2M | -6.33M | -7.95M | 1.83M | -5.16M | -7.81M | 27.86M | -7.88M | -6.6M | -7.08M | -8.06M | -6.89M |
Depreciation & Amortization | n/a | 35K | 81K | 49K | 49K | 61K | 71K | 84K | 91K | 106K | 116K | 123K | 150K | 178K | 161K | 222K | 276K | 242K | 256K | 295K | 299K | 294K |
Add to Watchlist
Select watchlists to add or remove APVO